Compounds > bosentan anhydrous
Page last updated: 2024-08-26

bosentan anhydrous and Telangiectasis

bosentan anhydrous has been researched along with Telangiectasis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bölke, E; Buhren, BA; Gerber, PA; Hetzer, S; Homey, B; Kammers, K; Meller, S; Schrumpf, H1
Kumarasinghe, SP; Tong, PL1

Trials

1 trial(s) available for bosentan anhydrous and Telangiectasis

ArticleYear
Retrospective analysis of the frequency of centrofacial telangiectasia in systemic sclerosis patients treated with bosentan or ilomedin.
    European journal of medical research, 2014, Jan-10, Volume: 19

    Topics: Adult; Aged; Aged, 80 and over; Bosentan; Face; Female; Humans; Iloprost; Linear Models; Male; Middle Aged; Retrospective Studies; Scleroderma, Systemic; Sulfonamides; Telangiectasis

2014

Other Studies

1 other study(ies) available for bosentan anhydrous and Telangiectasis

ArticleYear
Bosentan - a previously unrecognised cause of facial telangiectasia.
    Annals of the Academy of Medicine, Singapore, 2010, Volume: 39, Issue:11

    Topics: Aged; Antihypertensive Agents; Bosentan; Endothelin-1; Face; Female; Humans; Hypertension, Pulmonary; Sulfonamides; Telangiectasis

2010